Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000814078 | SCV004810425 | pathogenic | Severe combined immunodeficiency due to DCLRE1C deficiency | 2024-03-08 | reviewed by expert panel | curation | The c.522C>G (p.Tyr174Ter)(NM_001033855.3) variant in DCLRE1C is a nonsense variant predicted to cause a premature stop codon in biologically relevant exon 7/14 leading to nonsense-mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1 is met). This variant is absent from gnomAD v4 (PM2_Supporting). One patient reported in the literature is homozygous for this variant, 0.5 pts, PM3_Supporting. She is T-B-NK+ (0.5 pts) with diagnosis carried out through SCID gene panel or exome/genome sequencing conducted (0.5 pts), total 1 pt, PP4_Supporting (PMID: 37480474). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal recessive severe combined immunodeficiency due to DCLRE1C deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: PVS1, PM2_Supporting, PM3_Supporting, and PP4_Supporting (VCEP specifications version 1). |
Labcorp Genetics |
RCV000814078 | SCV000954475 | pathogenic | Severe combined immunodeficiency due to DCLRE1C deficiency | 2018-10-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr174*) in the DCLRE1C gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in DCLRE1C are known to be pathogenic (PMID: 21664875, 26123418). This variant has not been reported in the literature in individuals with DCLRE1C-related disease. This variant is not present in population databases (ExAC no frequency). |